Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Translational Development Acquisition (TDAC) Operating Income (2024 - 2026)

Translational Development Acquisition's Operating Income history spans 3 years, with the latest figure at -$281161.0 for Q1 2026.

  • On a quarterly basis, Operating Income rose 19.07% to -$281161.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$878291.0, a 61.52% decrease, with the full-year FY2025 number at -$944538.0, down 381.03% from a year prior.
  • Operating Income came in at -$281161.0 for Q1 2026, down from -$162345.0 in the prior quarter.
  • The five-year high for Operating Income was -$1685.0 in Q2 2024, with the low at -$347408.0 in Q1 2025.
  • Historically, Operating Income has averaged -$177757.1 across 3 years, with a median of -$188001.5 in 2025.
  • Biggest five-year swings in Operating Income: crashed 13023.26% in 2025 and later rose 19.07% in 2026.
  • Year by year, Operating Income stood at -$133390.0 in 2024, then decreased by 21.71% to -$162345.0 in 2025, then crashed by 73.19% to -$281161.0 in 2026.
  • Business Quant data shows Operating Income for TDAC at -$281161.0 in Q1 2026, -$162345.0 in Q4 2025, and -$213658.0 in Q3 2025.